Jason M. Meggs
Net Worth

Last updated:

What is Jason M. Meggs net worth?

The estimated net worth of Mr. Jason M. Meggs is at least $7,688,914 as of 18 Jul 2022. He has earned $2,326,004 from insider trading and has received compensation worth at least $5,362,910 in Syneos Health, Inc..

What is the salary of Jason M. Meggs?

Mr. Jason M. Meggs salary is $766,130 per year as Chief Financial Officer in Syneos Health, Inc..

How old is Jason M. Meggs?

Mr. Jason M. Meggs is 49 years old, born in 1976.

What stocks does Jason M. Meggs currently own?

As insider, Mr. Jason M. Meggs owns shares in one company:

Company Title Shares Price per share Total value
Syneos Health, Inc. (SYNH) Chief Financial Officer 54,736 $0 $0

What does Syneos Health, Inc. do?

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

SYNH logo
SYNH
Syneos Health, Inc.

Jason M. Meggs insider trading

Syneos Health, Inc.

Mr. Jason M. Meggs has made 8 insider trades between 2018-2022, according to the Form 4 filled with the SEC. Most recently he sold 7,500 units of SYNH stock worth $546,075 on 18 Jul 2022.

The largest trade he's ever made was exercising 9,223 units of SYNH stock on 3 Sep 2021. As of 18 Jul 2022 he still owns at least 54,736 units of SYNH stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Common Stock 7,500 $72.81 $546,075
Sale
Class A Common Stock 9,223 $95 $876,185
Sale
Class A Common Stock 40 N/A N/A
Option
Stock Option (Right to Buy Class A Common Stock) 620 N/A N/A
Option
Class A Common Stock 660 N/A N/A
Option
Class A Common Stock 660 N/A N/A
Option
Class A Common Stock 4,668 N/A N/A
Option
Stock Option (Right to Buy Class A Common Stock) 4,668 N/A N/A
Option
Stock Option (Right to Buy Class A Common Stock) 4,668 $66.44 $310,142
Sale
Class A Common Stock 2,068 N/A N/A
Sale
Class A Common Stock 6,000 $84 $504,000
Sale
Class A Common Stock 5,552 $72 $399,744
Sale
Class A Common Stock 4,062 N/A N/A
Sale
Class A Common Stock 1,938 N/A N/A
Purchase
Class A Common Stock 3,555 $36.38 $129,313
Purchase
Class A Common Stock 3,555 N/A N/A
Option
Class A Common Stock 5,094 N/A N/A
Option
Performance Restricted Stock Units 5,094 N/A N/A
Purchase
Class A Common Stock 3,650 N/A N/A

Syneos Health key executives

Syneos Health, Inc. executives and other stock owners filed with the SEC: